KNTE — Kinnate Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Kinnate Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	76.5	397	253	227	154
Net Total Receivables	0.973	0	—	—	—
Prepaid Expenses
Total Current Assets	77.5	400	259	231	158
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.154	0.368	0.956	6.45	4.76
Long Term Investments
Other Long Term Assets
Total Assets	77.6	401	367	279	174
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.95	7.3	12.4	17.2	12
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	1.95	7.3	47.4	55.4	14.3
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	75.7	393	319	223	159
Total Liabilities & Shareholders' Equity	77.6	401	367	279	174
Total Common Shares Outstanding